BE trial design as partial replicate and two stage [Regulatives / Guidelines]

posted by Silva – Portugal, 2014-04-17 10:57 (4453 d 21:22 ago) – Posting: # 12846
Views: 3,999

Dear all

Is it advisable to use two stage design approach in partial replicate design?
If yes, which alpha level should be used for the second stage (combined stage I + stage II data)?

Best regards
Silva

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
410 visitors (0 registered, 410 guests [including 18 identified bots]).
Forum time: 08:20 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5